Results
The mean age of the patients included the study was 64.8 ± 7.5 (51–77)
years, the mean time since diagnosis was 78.8 ± 21.9 (48–136) days, and
the mean total serum PSA level was 9.8 ± 5.5 (4.1–22) ng/mL. The
demographical data of the patients are listed in Table 1. Of the 24
patients whose operations were postponed, 14 (58.3%) patients were in
the low-risk group and 10 (41.7%) patients were in the medium-risk
group. Fourteen patients have Gleason 3+3, eight patients have Gleason 3
+ 4 and 2 patients have Gleason 4 + 3 prostatic adenocarcinoma.
The mean STAI-I score of the patients (46.7 ± 1.4 [44–49]) was
significantly higher than their STAI-II score (41.7 ± 2.4 [39–47])
(p < 0.001). The negative correlation between the decrease in
age and STAI-I score was found to be statistically significant (r =
0.439, p < 0.05). The mean BDI score of the patients was 4.3 ±
3.2 (0–13), which was compatible with mild depression. There was no
statistically significant difference between the time elapsed from
diagnosis, PSA levels, smoking and alcohol habitus, major surgical
history and comorbidity status, and STAI-I, STAI-II, and BDI scores
(p>0.05) (Table 2 and 3).